Table 7.
Outcome results
| CG (n = 15) | SG (n = 15) | OR (95% CI) | P value | |
|---|---|---|---|---|
| Secondary outcome | ||||
| PaO2/FiO2 (mmHg) | 298.67 (44.68) | 307.60 (48.22) | 0.63 (0.25–1.63) | 0.342 |
| Circulatory | 126 (3.0) | 141 (3.4) | 1.15 (0.91–1.48) | 0.249 |
| Gastrointestinal | 128 (7.6) | 90 (5.7) | 0.73 (0.56–0.97) | 0.026 |
| Renal | 34 (8.1) | 41 (10.3) | 1.31 (0.83–2.16) | 0.270 |
| Haematologic | 20 (2.4) | 17 (2.1) | 0.89 (0.45–1.68) | 0.745 |
| Infection | 7 (0.5) | 18 (1.5) | 3.03 (1.26–7.28) | 0.013 |
| Tertiary outcome | ||||
| ICU length of stay (days) | 4 [3, 4] | 3 [2–4] | 0.33 (0.08–1.48) | 0.108 |
| In-hospital stay (days) | 20.20 (13.08) | 18.23 (11.45) | 0.94 (0.21–4.29) | 0.678 |
| Mortality | 0 (0.0) | 1 (6.7) | 3.21 (0.12–85.20) | 0.486 |
| Composite outcome | 372 (7.1) | 350 (6.6) | 0.94 (0.81–1.09) | 0.396 |
Data are expressed as number n (%), mean (SD) or median [IQR]
CG control group; SG study group; OR odds ratio; PaO2/FiO2 ratio of arterial oxygen partial pressure to fraction of inspired oxygen; ICU intensive care unit
Italics value indicates number of subjects or number of events